首页> 外文OA文献 >A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease

【2h】

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease

机译：随机，双盲，安慰剂控制，期II研究评估苔藓醛酸的安全性，耐受性和功效治疗中度严重至严重的Alzheimer病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Martin R. Farlow; Richard E. Thompson; Lee-Jen Wei; Alan J. Tuchman; Elaine Grenier; David Crockford; Susanne Wilke; Jeffrey Benison; Daniel L. Alkon;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease [J] . Farlow Martin R., Thompson Richard E., Wei Lee-Jen, Journal of Alzheimer's disease: JAD . 2019,第2期

机译：随机，双盲，安慰剂控制，II期研究评估苔藓抑素治疗中度严重至严重阿尔茨海默病的安全性，耐受性和疗效
2. Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study [J] . Eser Alexander, Colombel Jean-Frederic, Rutgeerts Paul, Inflammatory bowel diseases . 2015,第10期

机译：嘌呤能受体P2X7口服抑制剂对中度至重度克罗恩病成年患者的安全性和有效性：一项随机安慰剂对照，双盲，IIa期研究
3. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study [J] . Sanga Panna, Polverejan Elena, Wang Steven, Clinical therapeutics . 2016,第6期

机译：控制性不佳，中度至重度慢性下腰痛患者的Fulranumab辅助治疗的疗效，安全性和耐受性：一项随机，双盲，安慰剂对照，剂量范围，剂量负荷II期研究
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. A Randomized Double-Blind Placebo-Controlled Phase II Study Assessing Safety Tolerability and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease [O] . Martin R. Farlow, Richard E. Thompson, Lee-Jen Wei, -1

机译：一项随机双盲安慰剂对照的II期临床研究评估Bryostatin治疗中度至重度阿尔茨海默氏病的安全性耐受性和有效性
7. Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Dose-loading Phase II Study [O] . Sanga Panna, Polverejan Elena, Wang Steven, 2016

机译：控制性不佳，中度至重度慢性下腰痛患者的Fulranumab辅助治疗的疗效，安全性和耐受性：一项随机，双盲，安慰剂对照，剂量范围，剂量负荷II期研究
8. Randomized Double-Blind Phase III Pivotal Field Trial of the Comparative Immunogenicity Safety and Tolerability of Two Yellow Fever 17D Vaccines (ARILVAX(Trademark) and YF-VAX(Trademark)) in Healthy Infants and Children in Peru [R] . Belmusto-Worn, V. E. , Sanchez, J. L. , McCarthy, K. , 2004

机译：秘鲁健康婴儿和儿童两种黄热病17D疫苗（aRILVaX（商标）和YF-VaX（商标））的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease

著录项

引文网络

相似文献

相关主题

期刊订阅